Koszenie trawy nie ominie nikogo, kto zdecydował się na założenie trawnika. Regularne koszenie jest ważne dla utrzymania ...

Traws Pharma (TRAW) is scheduled to report Q2 earnings on August 13, 2026. Analysts estimate EPS of $-0.40 and quarterly revenue of N/A. In the most recent quarter (Q1), Traws Pharma reported EPS of $ ...

Net Loss: $123.1 million for the quarter ended June 30, 2024. Net Loss Per Share: $4.87 per basic and diluted common share. Noncash Charge: $117.5 million related to in-process R&D from the ...

TRAWS PHARMA ($TRAW) posted quarterly earnings results on Monday, March 31st. The company reported earnings of $95.66 per share, beating estimates of -$9.74 by $105. ...

) has been revised to $8.16 / share. This is a decrease of 94.67% from the prior estimate of $153.00 dated February 16, 2025. The price target is an average of many targets provided by analysts. The ...

Ladies and gentlemen, thank you for standing by. Welcome to the Traws Pharma, Inc. Second Quarter 2025 Financial Results and Business Update Call. [Operator Instructions] As a reminder, this call is ...

NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then released ...

Revenue: $2.8 million for the year ended December 31, 2025, compared to $226,000 in 2024. Net Income: $9.2 million for the year ended December 31, 2025, compared to a net loss of $166.5 million in ...